OS Therapies Incorporated (OSTX) Balance Sheet
OSTX balance sheet, 2025
December 31, 2025 · U.S. dollars$6.8M assets = $12.9M liabilities + −$6.1M equity
Liabilities exceed assets: shareholders’ equity is negative (−$6.1M).
Both columns are drawn to the same scale: what OSTX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
OSTX financial health
Descriptive bands, not a rating. Fiscal 2025.
OSTX balance sheet trends, 2020–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.68B2020 | $6.8M2025 | −66.7%/yr | |
| Total liabilities | $8.00B2020 | $12.9M2025 | −72.4%/yr | |
| Shareholders’ equity | −$6.33B2020 | −$6.1M2025 | — | |
| Cash & short-term investments | $1.23B2020 | $269,8302025 | −81.5%/yr | |
| Total debt | $6.77B2020 | $6.0M2024 | −82.7%/yr | |
| Net cash (debt) | −$5.54B2020 | −$516,4732024 | +$5.5B | |
| Working capital | −$427.1M2020 | −$11.4M2025 | +$415.6M | |
| Book value per share | −$0.502021 | −$0.212025 | — | |
| Current ratio | 0.802020 | 0.032025 | −0.77 | |
| Shares outstanding | 23.1M2021 | 29.3M2025 | +6.1%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
OSTX assets
OSTX liabilities and equity
OSTX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
OSTX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & short-term investments | $269,830 | $5.5M | $38,982 | $171,480 | $80,788 | $1.23B |
| Cash & equivalents | $269,830 | $5.5M | $38,982 | $171,480 | $80,788 | $1.23B |
| Short-term investments | — | $5.53B | — | — | — | — |
| Receivables | $0 | $0 | $0 | $1,145 | $231,071 | $430.5M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $63,082 | $0 | $751,050 | $324,210 | $956 | $12.8M |
| Total current assets | $332,912 | $5.5M | $790,032 | $496,835 | $312,815 | $1.68B |
| Property, plant & equipment (net) | $2,490 | $5,270 | $8,050 | $12,270 | $13,076 | $1.9M |
| Goodwill & intangible assets | $6.5M | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $6.8M | $5.5M | $798,082 | $509,105 | $325,891 | $1.68B |
| Liabilities | ||||||
| Accounts payable | $9.9M | $1.7M | $2.7M | $1.2M | $856,521 | $40,000 |
| Short-term debt | — | — | $14.6M | $3.0M | $1.61B | $871.2M |
| Total current liabilities | $11.8M | $4.6M | $24.7M | $6.1M | $3.5M | $2.10B |
| Long-term debt | $0 | $0 | $0 | $10.3M | $7.1M | $0 |
| Other long-term liabilities | $1.2M | $100,000 | $100,000 | $1.6M | $1.2M | $5.90B |
| Total liabilities | $12.9M | $4.7M | $24.8M | $18.1M | $11.8M | $8.00B |
| Shareholders' equity | ||||||
| Common stock & paid-in capital | $37,116 | $20,870 | $5,340 | $4,990 | $9,980 | $8.8M |
| Retained earnings (deficit) | −$67.2M | −$40.4M | −$29.5M | −$21.6M | −$15.2M | −$6.34B |
| Accumulated other comprehensive income | — | — | — | — | — | $0 |
| Total shareholders' equity | −$6.1M | $811,487 | −$24.0M | −$17.6M | −$11.5M | −$6.33B |
| Key figures | ||||||
| Total debt | — | $6.0M | $14.6M | $10.3M | $7.1M | $6.77B |
| Net cash (debt) | — | −$516,473 | −$14.6M | −$10.2M | −$7.0M | −$5.54B |
| Working capital | −$11.4M | $906,217 | −$23.9M | −$5.7M | −$3.2M | −$427.1M |
| Tangible book value | −$12.6M | $811,487 | −$24.0M | −$17.6M | −$11.5M | −$6.33B |
| Book value per share | −$0.21 | $0.04 | −$1.20 | −$0.76 | −$0.50 | — |
| Shares outstanding | 29.3M | 20.9M | 20.0M | 23.1M | 23.1M | — |
| Current ratio | 0.03 | 1.20 | 0.03 | 0.08 | 0.09 | 0.80 |
| Quick ratio | 0.02 | 1.20 | 0.00 | 0.03 | 0.09 | 0.79 |
| Debt / equity | — | 7.46 | — | — | — | — |
| Equity / assets | −89.1% | 14.7% | −3,009.2% | −3,448.6% | −3,513.8% | −377.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $205,035 | $917,552 | $269,830 | $1.9M | $2.8M | $3.0M | $5.5M | $1.9M | $94,925 | $100,231 | $38,982 | $16,059 |
| Cash & equivalents | $205,035 | $917,552 | $269,830 | $1.9M | $2.8M | $3.0M | $5.5M | $1.9M | $94,925 | $100,231 | $38,982 | $16,059 |
| Receivables | $3.1M | $0 | $0 | $0 | $0 | $23,636 | $0 | $77,500 | $62,127 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $337,707 | $0 | $63,082 | $445,065 | $751,963 | $1.1M | $0 | $35,000 | $1.2M | $941,338 | $751,050 | $629,473 |
| Total current assets | $3.6M | $917,552 | $332,912 | $2.3M | $3.6M | $4.1M | $5.5M | $2.0M | $1.3M | $1.0M | $790,032 | $645,532 |
| Property, plant & equipment (net) | $1,100 | $1,795 | $2,490 | $3,185 | $3,880 | $4,575 | $5,270 | $6,660 | $6,660 | $7,355 | $8,050 | $8,069 |
| Goodwill & intangible assets | $6.3M | $6.4M | $6.5M | $6.6M | $6.8M | $150,000 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $9.9M | $7.3M | $6.8M | $9.0M | $10.3M | $4.2M | $5.5M | $2.0M | $1.3M | $1.0M | $798,082 | $653,601 |
| Liabilities | ||||||||||||
| Accounts payable | $18.9M | $15.2M | $9.9M | $3.4M | $2.7M | $1.6M | $1.7M | $1.8M | $2.9M | $2.8M | $2.7M | $2.5M |
| Short-term debt | — | $1.3M | — | — | — | — | — | — | $16.7M | $15.6M | $14.6M | — |
| Total current liabilities | $20.6M | $17.0M | $11.8M | $4.1M | $3.5M | $3.5M | $4.6M | $2.6M | $28.3M | $26.5M | $24.7M | $9.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $100,000 | $1.2M | $1.2M | $100,000 | $100,000 | $4.9M | $100,000 | $100,000 | $100,000 | $100,000 | $100,000 | $13.8M |
| Total liabilities | $20.6M | $18.1M | $12.9M | $4.2M | $3.6M | $8.4M | $4.7M | $2.7M | $28.4M | $26.6M | $24.8M | $23.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $45,283 | $39,278 | $37,116 | $33,270 | $29,665 | $21,348 | $20,870 | $21,181 | $5,991 | $5,991 | $5,340 | $10,680 |
| Retained earnings (deficit) | −$86.2M | −$77.6M | −$67.2M | −$53.7M | −$46.8M | −$42.3M | −$40.4M | −$35.4M | −$32.6M | −$31.0M | −$29.5M | −$28.0M |
| Total shareholders' equity | −$10.8M | −$10.8M | −$6.1M | $4.7M | $6.8M | −$4.2M | $811,487 | −$707,127 | −$27.1M | −$25.5M | −$24.0M | −$22.5M |
| Key figures | ||||||||||||
| Total debt | — | $1.3M | — | — | — | — | $6.0M | — | $16.7M | $15.6M | $14.6M | $13.5M |
| Net cash (debt) | — | −$425,390 | — | — | — | — | −$516,473 | — | −$16.6M | −$15.5M | −$14.6M | −$13.5M |
| Working capital | −$17.0M | −$16.0M | −$11.4M | −$1.8M | $95,942 | $559,091 | $906,217 | −$613,787 | −$27.0M | −$25.4M | −$23.9M | −$8.8M |
| Tangible book value | −$17.1M | −$17.2M | −$12.6M | −$1.9M | −$178 | −$4.3M | $811,487 | −$707,127 | −$27.1M | −$25.5M | −$24.0M | −$22.5M |
| Book value per share | −$0.25 | −$0.28 | −$0.21 | $0.15 | $0.27 | −$0.20 | $0.01 | −$0.04 | −$1.31 | −$1.27 | −$1.20 | −$0.97 |
| Shares outstanding | 43.9M | 38.7M | 29.3M | 32.0M | 25.1M | 21.2M | 123.8M | 15.9M | 20.6M | 20.0M | 20.0M | 23.1M |
| Current ratio | 0.18 | 0.05 | 0.03 | 0.56 | 1.03 | 1.16 | 1.20 | 0.76 | 0.05 | 0.04 | 0.03 | 0.07 |
| Quick ratio | 0.16 | 0.05 | 0.02 | 0.45 | 0.81 | 0.85 | 1.20 | 0.75 | 0.01 | 0.00 | 0.00 | 0.00 |
| Debt / equity | — | — | — | — | — | — | 7.46 | — | — | — | — | — |
| Equity / assets | −109.6% | −148.3% | −89.1% | 52.6% | 65.5% | −98.5% | 14.7% | −35.8% | −2,016.4% | −2,431.7% | −3,009.2% | −3,445.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.
OSTX financial position
At the end of fiscal 2025 (December 31, 2025), OS Therapies had total assets of $6.8 million (up 23.5% from a year earlier), total liabilities of $12.9 million and shareholders' equity of -$6.1 million. Its current ratio was 0.03. In the latest quarter (ended June 30, 2026) total assets were $9.9 million and equity -$10.8 million.
Related: OSTX income statement, OSTX cash flow statement, OSTX key metrics. See the OSTX stock overview for the latest quote and news.
OSTX balance sheet FAQ
What are OS Therapies's total assets?
OS Therapies reported total assets of $6.8 million at the end of fiscal 2025 (December 31, 2025), compared with $5.5 million a year earlier.
How much cash does OS Therapies have?
OS Therapies held $0.3 million in cash and short-term investments at the end of fiscal 2025.
What is OS Therapies's book value?
OS Therapies's shareholders' equity (book value) was -$6.1 million at the end of fiscal 2025, or −$0.21 per share.
What is OS Therapies's current ratio?
OS Therapies had current assets of $0.3 million and current liabilities of $11.8 million, a current ratio of 0.03 (current liabilities exceed current assets).
How much goodwill does OS Therapies have?
OS Therapies carried $6.5 million of goodwill and intangible assets, 95.1% of total assets, at the end of fiscal 2025.